Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

San Antonio, Texas 78229


Purpose:

The purpose of this study is to evaluate the effects of dapagliflozin to promote glucose loss in urine in healthy subjects and subjects with type 2 diabetes mellitus


Criteria:

Inclusion Criteria: - Male and female subjects - Age 18 to 65 years - BMI 18 to 35 kg/m2 - Healthy subjects and subjects with type 2 diabetes mellitus on 1 of the following therapies: diet, sulfonylurea, and/or metformin - No evidence of impaired renal function Exclusion Criteria: - Unwilling or unable to use an acceptable method of birth control - Subjects with type 1 diabetes mellitus, heart disease, hepatic C or B - Exposure to insulin - Use of exclusionary concomitant medications - Evidence of significant kidney disease or any other significant medical or psychiatric disorder


NCT ID:

NCT00726505


Primary Contact:

Study Director
Bristol-Myers Squibb
Bristol-Myers Squibb


Backup Contact:

N/A


Location Contact:

San Antonio, Texas 78229
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: March 16, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.